Abstract Glucocorticoid (GC) is currently the most effective drug for controlling persistent asthma; however, there is a significant difference in the response to GC among patients with asthma. Steroid-resistant asthma is one of the subtypes of asthma and has poor response to high-dose GC treatment. It may affect the quality of life of patients and even threaten their lives. Therefore, it is of great significance to explore the pathogenesis of steroid-resistant asthma and related targeted treatment strategy. In recent years, a variety of pathogeneses have been found to participate in the development and progression of steroid-resistant asthma, including the reduction in the binding between GC receptor and GC, the increase in the expression of GC receptor β, over-activation of nuclear transcription factor activating protein 1 and nuclear factor-κB, abnormality in histone acetylation, and immune-mediated cytokine dysregulation. In addition, many studies have shown that vitamin D can improve the sensitivity to GC among patients with steroid-resistant asthma. This article reviews the pathogenesis of steroid-resistant asthma and the influence of vitamin D.
Yang X, Jiang Y, Wang C. Does IL-17 respond to the disordered lung microbiome and contribute to the neutrophilic phenotype in asthma?[J]. Mediators Inflamm, 2016, 2016:6470364.
[4]
Chambers ES, Nanzer AM, Pfeffer PE, et al. Distinct endotypes of steroid-resistant asthma characterized by IL-17A(high) and IFN-gamma(high) immunophenotypes:potential benefits of calcitriol[J]. J Allergy Clin Immunol, 2015, 136(3):628-637.
[5]
Nanzer AM, Chambers ES, Ryanna K, et al. Enhanced production of IL-17A in patients with severe asthma is inhibited by 1α, 25-dihydroxyvitamin D3 in a glucocorticoid-independent fashion[J]. J Allergy Clin Immunol, 2013, 132(2):297-304.
[6]
Kerley CP, Elnazir B, Faul J, et al. Vitamin D as an adjunctive therapy in asthma. Part 1:a review of potential mechanisms[J]. Pulm Pharmacol Ther, 2015, 32:60-74.
[7]
Hamzaoui A, Berraies A, Hamdi B, et al. Vitamin D reduces the differentiation and expansion of Th17 cells in young asthmatic children[J]. Immunobiology, 2014, 219(11):873-879.
[8]
Maltby S, Tay HL, Yang M, et al. Mouse models of severe asthma:understanding the mechanisms of steroid resistance, tissue remodelling and disease exacerbation[J]. Respirology, 2017, 22(5):874-885.
[9]
Vargas JE, Porto BN, Puga R, et al. Identifying a biomarker network for corticosteroid resistance in asthma from bronchoalveolar lavage samples[J]. Mol Biol Rep, 2016, 43(7):697-710.
Rodriguez JM, Monsalves-Alvarez M, Henriquez S, et al. Glucocorticoid resistance in chronic diseases[J]. Steroids, 2016, 115:182-192.
[12]
Vazquez-Tello A, Halwani R, Hamid Q, et al. Glucocorticoid receptor-beta up-regulation and steroid resistance induction by IL-17 and IL-23 cytokine stimulation in peripheral mononuclear cells[J]. J Clin Immunol, 2013, 33(2):466-478.
[13]
Hansbro PM, Kim RY, Starkey MR, et al. Mechanisms and treatments for severe, steroid-resistant allergic airway disease and asthma[J]. Immunol Rev, 2017, 278(1):41-62.
[14]
Zhang Y, Leung DY, Goleva E. Vitamin D enhances glucocorticoid action in human monocytes:involvement of granulocyte-macrophage colony-stimulating factor and mediator complex subunit 14[J]. J Biol Chem, 2013, 288(20):14544-14553.
Lan N, Luo G, Yang X, et al. 25-Hydroxyvitamin D3-deficiency enhances oxidative stress and corticosteroid resistance in severe asthma exacerbation[J]. PLoS One, 2014, 9(11):e111599.
[17]
Mann EH, Chambers ES, Pfeffer PE, et al. Immunoregulatory mechanisms of vitamin D relevant to respiratory health and asthma[J]. Ann N Y Acad Sci, 2014, 1317:57-69.
[18]
Zhang Y, Leung DY, Goleva E. Anti-inflammatory and corticosteroid-enhancing actions of vitamin D in monocytes of patients with steroid-resistant and those with steroid-sensitive asthma[J]. J Allergy Clin Immunol, 2014, 133(6):1744-1752.
[19]
Barnes PJ. Corticosteroid resistance in patients with asthma and chronic obstructive pulmonary disease[J]. J Allergy Clin Immunol, 2013, 131(3):636-645.
[20]
赖天文. 组蛋白去乙酰化酶2及白慢阻肺及哮喘中的分子机制研究[D]. 杭州:浙江大学, 2017.
[21]
Irvin C, Zafar I, Good J, et al. Increased frequency of d介素17A在ual-positive TH2/TH17 cells in bronchoalveolar lavage fluid characterizes a population of patients with severe asthma[J]. J Allergy Clin Immunol, 2014, 134(5):1175-1186.
[22]
Kim RY, Pinkerton JW, Essilfie AT, et al. Role for NLRP3 inflammasome-mediated, IL-1β-dependent responses in severe, steroid-resistant asthma[J]. Am J Respir Crit Care Med, 2017, 196(3):283-297.
[23]
Mikami Y, Matsuzaki H, Horie M, et al. Lymphotoxin beta receptor signaling induces IL-8 production in human bronchial epithelial cells[J]. PLoS One, 2014, 9(12):e114791.
[24]
Suzuki Y, Maazi H, Sankaranarayanan I, et al. Lack of autophagy induces steroid-resistant airway inflammation[J]. J Allergy Clin Immunol, 2016, 137(5):1382-1389.
[25]
Dejager L, Dendoncker K, Eggermont M, et al. Neutralizing TNFα restores glucocorticoid sensitivity in a mouse model of neutrophilic airway inflammation[J]. Mucosal Immunol, 2015, 8(6):1212-1225.
[26]
O'Connell D, Bouazza B, Kokalari B, et al. IFN-γ-induced JAK/STAT, but not NF-κB, signaling pathway is insensitive to glucocorticoid in airway epithelial cells[J]. Am J Physiol Lung Cell Mol Physiol, 2015, 309(4):L348-L359.
[27]
Gauthier M, Chakraborty K, Oriss TB, et al. Severe asthma in humans and mouse model suggests a CXCL10 signature underlies corticosteroid-resistant Th1 bias[J]. JCI Insight, 2017, 2(13). pii:94580.
[28]
Afsal K, Selvaraj P, Harishankar M. 1, 25-dihydroxyvitamin D3 downregulates cytotoxic effector response in pulmonary tuberculosis[J]. Int Immunopharmacol, 2018, 62:251-260.
[29]
Shirazi HA, Rasouli J, Ciric B, et al. 1,25-Dihydroxyvitamin D3 suppressed experimental autoimmune encephalomyelitis through both immunomodulation and oligodendrocyte maturation[J]. Exp Mol Pathol, 2017, 102(3):515-521.
Kundu R, Theodoraki A, Haas CT, et al. Cell-type-specific modulation of innate immune signalling by vitamin D in human mononuclear phagocytes[J]. Immunology, 2017, 150(1):55-63.
[32]
Kabata H, Moro K, Fukunaga K, et al. Thymic stromal lymphopoietin induces corticosteroid resistance in natural helper cells during airway inflammation[J]. Nat Commun, 2013, 4:2675.
[33]
Saglani S. Childhood severe asthma:new insights on remodelling and biomarkers[J]. Paediatr Respir Rev, 2017, 24:11-13.
[34]
Kabata H, Moro K, Koyasu S, et al. Mechanisms to suppress ILC2-induced airway Inflammation[J]. Ann Am Thorac Soc, 2016, 13 Suppl 1:S95.
[35]
Khorasanizadeh M, Eskian M, Gelfand EW, et al. Mitogen-activated protein kinases as therapeutic targets for asthma[J]. Pharmacol Ther, 2017, 174:112-126.
[36]
Li LB, Leung DY, Goleva E. Activated p38 MAPK in peripheral blood monocytes of steroid resistant asthmatics[J]. PLoS One, 2015, 10(10):e0141909.
[37]
Lea S, Harbron C, Khan N, et al. Corticosteroid insensitive alveolar macrophages from asthma patients; synergistic interaction with a p38 mitogen-activated protein kinase (MAPK) inhibitor[J]. Br J Clin Pharmacol, 2015, 79(5):756-766.
[38]
Xu QA, Li ZF, Zhang P, et al. Effects of 1,25-dihydroxyvitamin D3 on macrophage cytokine secretion stimulated by porphyromonas gingivalis[J]. Jpn J Infect Dis, 2016, 69(6):482-487.
[39]
Bahar-Shany K, Ravid A, Koren R. Upregulation of MMP-9 production by TNF alpha in keratinocytes and its attenuation by vitamin D[J]. J Cell Physiol, 2010, 222(3):729-737.
Hosoda H, Tamura H, Nagaoka I. Evaluation of the lipopolysaccharide-induced transcription of the human TREM-1 gene in vitamin D3-matured THP-1 macrophage-like cells[J]. Int J Mol Med, 2015, 36(5):1300-1310.
[45]
Tian BP, Xia LX, Bao ZQ, et al. Bcl-2 inhibitors reduce steroid-insensitive airway inflammation[J]. J Allergy Clin Immunol, 2017, 140(2):418-430.
Kobayashi Y, Mercado N, Barnes PJ, et al. Defects of protein phosphatase 2A causes corticosteroid insensitivity in severe asthma[J]. PLoS One, 2011, 6(12):e27627.
Fuerst E, Foster HR, Ward JP, et al. Sphingosine-1-phosphate induces pro-remodelling response in airway smooth muscle cells[J]. Allergy, 2014, 69(11):1531-1539.
[55]
Sousa AR, Marshall RP, Warnock LC, et al. Responsiveness to oral prednisolone in severe asthma is related to the degree of eosinophilic airway inflammation[J]. Clin Exp Allergy, 2017, 47(7):890-899.
Marcinkowska E, Gocek E. Heat shock protein 90 interacts with vitamin D receptor in human leukemia cells[J]. J Steroid Biochem Mol Biol, 2010, 121(1-2):114-116.
